COMPANY
Kaer Biotherapeutics
NIH awards 4
- NIH award 5R44HL127834-03 FY2019: $976,638 awarded for that fiscal year; activity R44 (SBIR); PI YEATES, DONOVAN BYRON; recipient as written: KAER BIOTHERAPEUTICS CORPORATION, ESCONDIDO, CA. Aerosol Delivery of Surfa source ↗
- NIH award 1R43HL142335-01A1 FY2019: $299,719 awarded for that fiscal year; activity R43 (SBIR); PI YEATES, DONOVAN BYRON; recipient as written: KAER BIOTHERAPEUTICS CORPORATION, ESCONDIDO, CA. Non-Invasive Surfactant source ↗
- NIH award 2R44HL127834-02A1 FY2018: $986,436 awarded for that fiscal year; activity R44 (SBIR); PI YEATES, DONOVAN BYRON; recipient as written: KAER BIOTHERAPEUTICS CORPORATION, ESCONDIDO, CA. Aerosol Delivery of Sur source ↗
- NIH award 1R43HL127834-01 FY2015: $290,883 awarded for that fiscal year; activity R43 (SBIR); PI YEATES, DONOVAN BYRON; recipient as written: KAER BIOTHERAPEUTICS CORPORATION, ESCONDIDO, CA. Aerosol Delivery of Surfa source ↗